{
  "id": 4622012,
  "title": "All you need to know about: Chronic Lymphocytic Leukemia (CLL)",
  "url": "https://urgent.news/2026/08/31/all-you-need-to-know-about-chronic-lymphocytic-leukemia-cll-4622012",
  "topic": "science",
  "section": "Science",
  "published": "2026-08-31T10:00:53.000Z",
  "source": {
    "name": "The Hindu - Sci-Tech",
    "slug": "the-hindu-sci-tech",
    "url": "https://www.thehindu.com/sci-tech/health/all-you-need-to-know-about-chroniclymphocytic-leukemia-cll/article71399783.ece"
  },
  "original_language": "en",
  "account": "Chronic lymphocytic leukemia (CLL) is a type of blood cancer that impacts the blood and bone marrow. It is a less common form of leukemia in India, accounting for fewer than 5% of all leukemia cases, according to a 2025 European Society of Medicine paper. CLL is characterized by the abnormal proliferation of lymphocytes, a type of white blood cell, in the body. These cells play a crucial role in the immune system, helping the body combat infections. However, in CLL, the white blood cell count remains elevated even after an infection has cleared the body. The prognosis for CLL is generally slower than other types of leukemia, with no specific known cause. Many cases are discovered incidentally during routine blood tests, as the condition often does not present noticeable symptoms initially. When symptoms do appear, they may include swollen lymph nodes, weakness, weight loss, fever, anemia, and low platelet counts. There are three stages of CLL, with Stage A being asymptomatic and Stages B and C involving lymph node swelling and additional symptoms, respectively. Treatment for CLL varies depending on the stage, symptoms, overall health, and specific genetic and molecular characteristics of the disease. In early, asymptomatic cases, a \"watch and wait\" approach may be adopted, with regular blood tests and clinical evaluations. As the disease progresses and treatment becomes necessary, targeted oral therapies such as BTK inhibitors and BCL2 inhibitors, along with anti-CD20 antibodies, are commonly used. These treatments are tailored to the individual patient, aiming to control the disease effectively while maintaining quality of life and minimizing side effects.",
  "summary": "CLL is sometimes discovered by chance during a regular blood check, in particular if lymphocyte counts are abnormally high",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Hindu Health",
        "title": "All you need to know about: Chronic Lymphocytic Leukemia (CLL)",
        "url": "https://urgent.news/2026/08/31/all-you-need-to-know-about-chronic-lymphocytic-leukemia-cll",
        "published": "2026-08-31T10:00:53.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}